What is HCPCS code C9172?

C9172 is the HCPCS Level II code for Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose. It falls in Section C (Outpatient PPS (Hospital)) of the 2026 HCPCS Level II code set maintained by CMS.

Is C9172 covered by Medicare?

Medicare coverage status for C9172 is: Special coverage instructions apply. Always confirm current coverage with the payer.

Under Medicare Part B, C9172 is priced as: Statute.

C9172 Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose

Short descriptor: Inj, beqvez, per tx dose

⚠ Terminated HCPCS Level II 2026

Terminated Code

C9172 was terminated as of 2024-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.

Open C9172 in the app →

Look up C9172 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9172 is the HCPCS Level II code for Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Section: C: Outpatient PPS (Hospital)
Medicare Coverage: Special coverage instructions apply (code D)
Part B Pricing: Statute (indicator 53)
Type of Service: Medical care
Effective Date: 2025-01-01
Termination Date: 2024-12-31
2026 Maintenance: No change this year

References

Cite This Page

Reference C9172 with the canonical source and edition:

C9172 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9172

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9172

C9172 Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose

Classification & CMS Attributes

References

Cite This Page

Related Codes in Section C

Get HCC Mappings, Clinical Summaries, and More